PSYC Interviews Chief Architects and Petitioners of Oregon's Psilocybin Therapy Initiative
July 21 2020 - 8:30AM
InvestorsHub NewsWire
LAS VEGAS, NV -- July 21, 2020 --
InvestorsHub NewsWire -- Global Trac Solutions, Inc. (OTCPink:
PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce
the release of a special edition of its Microdose Monthly
newsletter featuring an exclusive interview conducted by PSYC CEO,
David Flores, and long-time psilocybin therapy advocates and Chief
Petitioners of Initiative Petition 34 (“IP 34”) in the state of
Oregon, Tom and Sheri Eckert.
Distributed this morning to
Microdose Monthly subscribers, and now live on the Psychedelic
Spotlight website under Spotlight Originals, the interview
highlights the recent accomplishment of the IP 34 campaign team,
guided, and led by chief architects, Tom and Sheri Eckert, in
helping to secure the nearly 165,000 signatures required to place
the initiative on the ballot in Oregon this November and providing
Oregonians with the opportunity to potentially green light a state
licensed and regulated psilocybin therapy program within the
state.
According to data provided by
Mental Health America, Oregon is currently
ranked as one of the worst/bottom states in the U.S. in terms of
its prevalence of mental health illnesses and disorders amongst its
residents in addition to significantly lower rates of access to
care when compared to other states. Such conditions, compounded by
the recent COVID-19 pandemic, have created a significant mental
health epidemic within the state and particularly for those
struggling with a variety of illnesses and disorders such as
depression, anxiety, and addiction. Based on encouraging data from
research and studies performed by leading medical research
institutions such as Johns Hopkins, UCLA, and NYU, Psilocybin
therapy through IP 34 aims to provide Oregonians with a much needed
alternative to conventional, and mostly pharma-based drugs, whereby
placing more emphasis on treatment over
management.
“I would first like to extend my
sincerest gratitude and congratulations to Tom and Sheri Eckert for
their tireless efforts, leadership, and dedication that have
contributed to IP 34 earning a very important spot on the November
ballot in Oregon,” said Global Trac Solutions, Inc. CEO, David
Flores. “This represents a potentially exciting and critical step
forward for the thousands of Oregonians struggling everyday with a
variety of debilitating mental health illnesses and disorders in
terms of laying the groundwork for expanded treatment options
highlighted by a licensed and regulated psilocybin therapy program.
In my opinion, this also represents an especially significant step
forward for the psychedelic reform movement and industry as a whole
and demonstrates the tangible momentum it is continuing to gain.
And as this momentum continues to pick up traction, I look forward
to maximizing the use of our Psychedelic Spotlight (www.psychedelicspotlight.com)and Microdose Monthly
platforms to showcase many other leaders within this space who are
contributing to its growth and emergence as a legitimate and
full-fledged industry.”
PSYC encourages those interested
in learning more about IP 34, or contributing to the initiative, to
visit the campaigns primary website at: https://yesonip34.org
About Global Trac Solutions, Inc.
(OTC
Pink:PSYC)
Global Trac Solutions is a
diversified holding company dedicated to identifying new and
emerging industries. By utilizing our years of business development
expertise our diverse team of innovators continuously leverages our
experience to effectively execute go-to-market strategies in order
to position ourselves for rapid growth through the creation of an
evolving business foundation to enhance profitability
potential.
PSYC has expressed its intent and
commitment to positioning itself at the forefront of the
psychedelic revolution and as a resource center for discovering and
understanding the latest research and business opportunities
surrounding psychedelic inspired medicines. In conjunction with the
FDA’s more open-minded approach to psychedelic medicines, and as
several major U.S. cities continue to approve the decriminalization
of psilocybin, investors are speculating that the psychedelic boom
could be bigger than that of cannabis. PSYC is your source for
current investment related news specific to psychedelic medicines
and cutting-edge research improving overall health, moving this
sector into the mainstream.
We believe in a forward-thinking
approach that embraces groundbreaking new technology and
innovations and through the vision of business development we
intend to continue to evolve into these unchartered territories as
the industry leaders of the future. We truly are the right TRAC to
follow.
Forward-Looking Statements
Disclaimer:
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. In some cases, you can
identify forward-looking statements by the following words:
"anticipate," "believe," "continue," "could," "estimate," "expect,"
"intend," "may," "ongoing," "plan," "potential," "predict,"
"project," "should," "will," "would," or the negative of these
terms or other comparable terminology, although not all
forward-looking statements contain these words. Forward-looking
statements are not a guarantee of future performance or results and
will not necessarily be accurate indications of the times at, or
by, which such performance or results will be achieved.
Forward-looking statements are based on information available at
the time the statements are made and involve known and unknown
risks, uncertainty and other factors that may cause our results,
levels of activity, performance or achievements to be materially
different from the information expressed or implied by the
forward-looking statements in this press release. This press
release should be considered in light of all filings of the Company
that are disclosed on the OTC Markets.com
website.
Corporate
Contact:
Global Trac Solutions, Inc.
(PSYC)
www.globaltracsolutions.com
(702) 239-1919
info@globaltracsolutions.com
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Apr 2024 to May 2024
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From May 2023 to May 2024